Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19): A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers

Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19): A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers

Background: As the coronavirus disease 2019 (COVID-19) pandemic progressed, especially with the emergence of the Omicron variant, the proportion of infected children and adolescents increased significantly. Some treatment such as Chinese herbal medicine has been administered for COVID-19 as a therap...

Full description

Bibliographic Details
Main Authors: Qian Dong, Hongmei Qiao, Huiyi Jiang, Lixiao Liu, Yanling Ge, Fang-Jiao Zong, Yanan Li, Bingzi Dong, Sujuan Hu, Dongmei Meng, Rong Jin, Xiangshi Wang, Hailing Chang, Xiaolong Xu, Chenjing Wang, Yu Cao, Han-Ting Zhang, Qingquan Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pharmacology
Subjects:
traditional Chinese medicine
Jin-Zhen oral liquid
pediatric COVID-19
randomized controlled clinical trial
multiple clinical centers
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1094089/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1094089/full

Similar Items